← Back to news

Markets

Broadcom (AVGO) and Canonical Announce An Expanded Collaboration

Y

Taiwan Semiconductor Manufacturing Company Limited (TSM) Highlights Key Changes and Activities

Y

Alphabet Inc. (NASDAQ:GOOGL): Waymo Receives First Permit to Start Testing AVs in New York City, Reports Reuters

Y

Susquehanna Reiterates Buy Rating on NVIDIA (NVDA) Stock

Y

Meta Platforms (META) Pauses Hiring in AI Division

Y

Amazon.com (AMZN): Procore Technologies, Inc. Signs Multi-year SCA With AWS

Y

Ambarella, Inc. (AMBA) Q2 2026 Earnings Call Transcript

S

Explainer-What the end of the de minimis exemption means for US shoppers and businesses

Y

US tariff exemption for low-value packages ends with few hiccups but higher costs loom

Y

Politics And The Markets 08/29/25

S

Are Catch-Up Contributions Worth It at 55 With $1.2M in a 401(k)?

Y

Jim Cramer Says “We Need a Healthy, Viable Intel”

Y

Jim Cramer on Ouster: “It is Fine as a Spec”

Y

Jim Cramer Says “Apollo’s a Cheap Stock”

Y

Telsey Advisory Maintains Buy Rating on Birkenstock Holding, Keeps PT at $70

Y

Jim Cramer on Powell Industries: “I Wish I Owned for the Trust”

Y

Bernstein Reiterates Buy Rating on On Holding AG Stock, Keeps PT at $70

Y

Jim Cramer on Robinhood: “Let it Calm Down”

Y

Jim Cramer Discusses Role of Kurt Wolf in Pitney Bowes Rebound

Y

Stifel Raises PT on Wolverine World Wide from $30 to $36, Keeps Buy Rating

Y

Jim Cramer on UnitedHealth: “They Got to Answer Some Tough Questions”

Y

BTIG Reiterates Buy Rating on Steven Madden Stock, Sets PT at $34

Y

Jim Cramer Says CVS “Has Proven to Be a Port in the Storm for Healthcare Investors”

Y

Here Is What to Expect From Designer Brands’ Second Quarter 2025 Earnings on September 9

Y

Jim Cramer is “Confident That Home Depot’s a Long-Term Story”

Y

Jim Cramer Discusses His Bearish Sentiment Around Salesforce

Y

Jim Cramer Believes “Anyone Who Refuses to Buy NVIDIA’s Chips Will Be Left Behind”

Y

US Bitcoin Mining Company Backed by Trump Sons Eyes Nasdaq Listing Following Merger

Y

FDA Accepts a New Drug Application From Rhythm Pharmaceuticals (RYTM)

Y

Morgan Stanley Raises PT on Halozyme Therapeutics (HALO), After Q2 Results

Y

Klaviyo (KVYO) Announces Availablity of its Enhanced Model Context Protocol server

Y

J.P. Morgan Raises the PT on Ionis Pharmaceuticals (IONS), Keeps a Hold Rating

Y

Jazz Pharmaceuticals (JAZZ) Sings License with Saniona for SAN2355

Y

Leerink Partners Maintains a Buy on Madrigal Pharmaceuticals (MDGL), Here’s Why

Y

Wall Street is Bullish on EPAM Systems (EPAM), Here’s Why

Y

How’s the Wall Street Reacting to ServiceTitan Inc’s (TTAN) FQ1 2026 Results

Y

Roivant Sciences (ROIV) Announces Q1 2025 Business Update

Y

Here’s What Wall Street Thinks About BridgeBio Pharma (BBIO)

Y

Here’s How Wall Street is Reacting to Verona Pharma (VRNA)’s Acquisition

Y

Morgan Stanley Maintains a Buy on monday.com (MNDY), After Q2 Report

Y

Here’s What the Wall Street Thinks About Revolution Medicines (RVMD)

Y

Galiano Gold Inc (GAU) Announces New Drilling Results from Abore Project

Y

How’s the Market Reacting to SNDL Inc’s (SNDL) Q2 Results?

Y

Ondas Holdings (ONDS) To Acquire Apeiro Motion

Y

Tilray Brands (TLRY)’s Breckenridge Distillery Launches Mountain Shot

Y

Canaccord Genuity Maintains a Buy on Holley (HLLY), Keeps the PT

Y

H.C. Wainwright Reiterates a Buy on United States Antimony Corporation (UAMY)

Y

ATRenew Inc (RERE) Reports FQ2 2025 Results

Y

RBA Warns of Financial Stability Risks From Private Market Boom

Y

Prudential Poised for Growth in All Markets, CEO Says

Y